These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 36387090)
21. Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma. Zheng W; Zhu W; Yu S; Li K; Ding Y; Wu Q; Tang Q; Zhao Q; Lu C; Guo C BMC Cancer; 2020 Nov; 20(1):1066. PubMed ID: 33148204 [TBL] [Abstract][Full Text] [Related]
22. Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapy. Duan J; Deng T; Ying G; Huang D; Zhang H; Zhou L; Bai M; Li H; Yang H; Qu Y; Wang X; Ba Y Jpn J Clin Oncol; 2016 Apr; 46(4):336-43. PubMed ID: 26819278 [TBL] [Abstract][Full Text] [Related]
23. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy. Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197 [TBL] [Abstract][Full Text] [Related]
24. Development and Validation of Nomograms to Predict Overall Survival Outcomes in Serous Ovarian Cancer Patients with Satisfactory Cytoreductive Surgery and Chemotherapy. Liu YY; Zhao RF; Liu C; Zhou J; Yang L; Li L Int J Gen Med; 2022; 15():123-131. PubMed ID: 35023951 [TBL] [Abstract][Full Text] [Related]
25. Prognostic nomograms for predicting overall survival and cause-specific survival of signet ring cell carcinoma in colorectal cancer patients. Kou FR; Zhang YZ; Xu WR World J Clin Cases; 2021 Apr; 9(11):2503-2518. PubMed ID: 33889615 [TBL] [Abstract][Full Text] [Related]
26. Development and validation of a nomogram for predicting survival of breast cancer patients with ipsilateral supraclavicular lymph node metastasis. Lyu MH; Ma YZ; Tian PQ; Guo HH; Wang C; Liu ZZ; Chen XC Chin Med J (Engl); 2021 Nov; 134(22):2692-2699. PubMed ID: 34743149 [TBL] [Abstract][Full Text] [Related]
27. Development and Validation of Nomograms Predicting the Overall and the Cancer-Specific Survival in Endometrial Cancer Patients. Li X; Fan Y; Dong Y; Cheng Y; Zhou J; Wang Z; Li X; Wang J Front Med (Lausanne); 2020; 7():614629. PubMed ID: 33425959 [No Abstract] [Full Text] [Related]
28. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics. Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306 [TBL] [Abstract][Full Text] [Related]
29. Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma. Chi DS; Palayekar MJ; Sonoda Y; Abu-Rustum NR; Awtrey CS; Huh J; Eisenhauer EL; Barakat RR; Kattan MW Gynecol Oncol; 2008 Jan; 108(1):191-4. PubMed ID: 17950784 [TBL] [Abstract][Full Text] [Related]
30. Establishment and Validation of a Nomogram for Nasopharyngeal Carcinoma Patients Concerning the Prognostic Effect of Parotid Lymph Node Metastases. Lin C; Sun XS; Liu SL; Li XY; Lu N; Li XL; Tang LQ; Guo L Cancer Res Treat; 2020 Jul; 52(3):855-866. PubMed ID: 32164051 [TBL] [Abstract][Full Text] [Related]
31. Nomogram of Combining CT-Based Body Composition Analyses and Prognostic Inflammation Score: Prediction of Survival in Advanced Epithelial Ovarian Cancer Patients. Wang X; Zhang C; Cao F; Wang CB; Dong JN; Wang ZH Acad Radiol; 2022 Sep; 29(9):1394-1403. PubMed ID: 34955366 [TBL] [Abstract][Full Text] [Related]
32. A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma. Zivanovic O; Jacks LM; Iasonos A; Leitao MM; Soslow RA; Veras E; Chi DS; Abu-Rustum NR; Barakat RR; Brennan MF; Hensley ML Cancer; 2012 Feb; 118(3):660-9. PubMed ID: 21751199 [TBL] [Abstract][Full Text] [Related]
33. Construction and validation of the prognostic model for patients with neuroendocrine cervical carcinoma: a competing risk nomogram analysis. Jiang AG; Cai X BMC Cancer; 2022 Jan; 22(1):4. PubMed ID: 34980030 [TBL] [Abstract][Full Text] [Related]
34. Predicting 5-Year Progression and Survival Outcomes for Early Stage Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiation Therapy: Development and Validation of Robust Prognostic Nomograms. Kang J; Ning MS; Feng H; Li H; Bahig H; Brooks ED; Welsh JW; Ye R; Miao H; Chang JY Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):90-99. PubMed ID: 31586665 [TBL] [Abstract][Full Text] [Related]
35. Nomogram for Predicting Recurrence-Free Survival in Chinese Women with Endometrial Cancer after Initial Therapy: External Validation. Cheng Y; Dong Y; Tian W; Zhang H; Li X; Wang Z; Shan B; Ren Y; Wei L; Wang H; Wang J J Oncol; 2020; 2020():2363545. PubMed ID: 32565798 [TBL] [Abstract][Full Text] [Related]
36. Development and External Validation of a Novel Model for Predicting Postsurgical Recurrence and Overall Survival After Cytoreductive R0 Resection of Epithelial Ovarian Cancer. Li Q; Deng Y; Wei W; Yang F; Lin A; Yao D; Zhu X; Li J Front Oncol; 2022; 12():859409. PubMed ID: 35402239 [TBL] [Abstract][Full Text] [Related]
37. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection. Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885 [TBL] [Abstract][Full Text] [Related]
38. Development and Validation of Prognostic Nomogram for Primary Peritoneal Serous Carcinoma Compared With FIGO Staging System: A Population-Based Study. Chen M; Wen Z; Qi Z; Gao M Front Oncol; 2021; 11():651969. PubMed ID: 34490079 [TBL] [Abstract][Full Text] [Related]
39. Construction and Validation of a Nomogram for Predicting Progression- Free Survival in Patients with Early-Stage Testicular Germ Cell Tumor. Chen JG; Wang JQ; Peng TW; Chen ZS; Zhao SC Recent Pat Anticancer Drug Discov; 2021; 16(1):44-53. PubMed ID: 33573563 [TBL] [Abstract][Full Text] [Related]
40. Residual Tumor Diameter Predicts Progression After Primary Debulking Surgery of Ovarian Clear Cell Carcinoma (OCCC): Clinicopathologic Study of Stage II-IV OCCC Patients from a Single Institution. Shi Y; Dai M; Zhang Y; Qi Y; Li Z; Cai H Cancer Manag Res; 2021; 13():2215-2222. PubMed ID: 33692636 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]